reperfusion

Systemic endothelin receptor blockade in ST-segment elevation acute coronary syndrome protects the microvasculature: a randomised pilot study

• Adlbrecht C,
• Andreas M,
• Redwan B,
• Distelmaier K,
• Mascherbauer J,
• Kaider A,
• Wolzt M,
• Tilea I-A,
• Neunteufl T,
• Delle-Karth G,
• Maurer G,
• Lang I

EuroIntervention 2012;7:1386-1395

Published in Volume 7 Number 12, April 2012

Acute haemodynamic effects of accelerated idioventricular rhythm in primary percutaneous coronary intervention

• Delewi R,
• Remmelink M,
• Meuwissen M,
• van Royen N,
• Vis M,
• Koch K,
• Henriques J,
• de Winter R,
• Tijssen J,
• Baan J,
• Piek J

EuroIntervention 2011;7:467-471

Published in Volume 7 Number 4, August 2011

Intracoronary application of abciximab in patients with ST-elevation myocardial infarction

• Wöhrle J,
• Nusser T,
• Mayer C,
• Kochs M,
• Hombach V

EuroInterv.2008;3:465-469

Published in Volume 3 Number 4, January 2008

The impact of age and Killip class on outcomes of primary percutaneous coronary intervention.
Insight from the PRAGUE-1 and -2 trials and registry

• Widimsky P,
• Motovská Z,
• Bílková D,
• Aschermann M,
• Groch L,
• Zelízko M

EuroInterv.2007;2:481-486

Published in Volume 2 Number 4, February 2007

CMR assessment of AMI patients treated by PCI shows delays in myocardial reperfusion despite initial achievement of TIMI 3 flow

• Noël B,
• Morice M-C,
• Garot J,
• Louvard Y,
• Tavolaro O,
• Dumas P,
• Lévy M,
• Garot P,
• Lefèvre T

EuroInterv.2005;2:214-218

Published in Volume 1 Number 2, August 2005